Histopathological evaluation of RPL5 expression in triple-negative breast cancer: an integrated immunohistochemical and transcriptomic study
Bing Zhao, Peiyuan Yu, Li Li, Zhenhui Zhao, Xiner Zhang · 2026
Read Histopathological evaluation of RPL5 expression in triple-negative breast cancer: an integrated immunohistochemical and transcriptomic study by Bing Zhao, Peiyuan Yu, Li Li, Zhenhui Zhao, Xiner Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13535662.txt.
Description
Bing Zhao and colleagues evaluate in 2026 RPL5, a ribosomal protein, in triple-negative breast cancer, an aggressive subtype with few treatment options. Tissue from 37 patients and nearby normal tissue was stained for the protein, and public gene datasets added a second check. The team also mapped genes that move together with RPL5.
Staining showed lower RPL5 protein in tumours than in nearby normal tissue, while gene data showed higher levels in this subtype than in other breast cancers. Levels did not track with stage, spread, or survival in this group. Linked genes centred on ribosome building and p53 pathways.
Catalog record
| CREATOR | Bing Zhao, Peiyuan Yu, Li Li, Zhenhui Zhao, Xiner Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45521 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |